KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Current Assets (2016 - 2025)

Historic Current Assets for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $1.6 billion.

  • Exact Sciences' Current Assets fell 99.11% to $1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year decrease of 99.11%. This contributed to the annual value of $1.6 billion for FY2025, which is 99.11% down from last year.
  • As of Q4 2025, Exact Sciences' Current Assets stood at $1.6 billion, which was down 99.11% from $1.6 billion recorded in Q3 2025.
  • Exact Sciences' Current Assets' 5-year high stood at $1.8 billion during Q1 2021, with a 5-year trough of $982.3 million in Q4 2022.
  • Its 5-year average for Current Assets is $1.4 billion, with a median of $1.4 billion in 2021.
  • In the last 5 years, Exact Sciences' Current Assets tumbled by 3512.96% in 2021 and then soared by 3352.51% in 2024.
  • Over the past 5 years, Exact Sciences' Current Assets (Quarter) stood at $1.4 billion in 2021, then plummeted by 31.13% to $982.3 million in 2022, then rose by 21.59% to $1.2 billion in 2023, then skyrocketed by 31.57% to $1.6 billion in 2024, then decreased by 0.99% to $1.6 billion in 2025.
  • Its Current Assets stands at $1.6 billion for Q4 2025, versus $1.6 billion for Q3 2025 and $1.5 billion for Q2 2025.